UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives

The Journal of clinical investigation, 2018-04, Vol.128 (4), p.1208-1216

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics

PloS one, 2013-05, Vol.8 (5), p.e63644-e63644

2013

Link zum Volltext

Verfügbarkeit prüfen

Physical Exercise as a Preventive or Disease-Modifying Treatment of Dementia and Brain Aging

Mayo Clinic proceedings, 2011-09, Vol.86 (9), p.876-884

2011

Link zum Volltext

Verfügbarkeit prüfen

Mild Cognitive Impairment and Mild Dementia: A Clinical Perspective

Mayo Clinic proceedings, 2014-10, Vol.89 (10), p.1452-1459

2014

Link zum Volltext

Verfügbarkeit prüfen

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Lancet neurology, 2013-02, Vol.12 (2), p.207-216

2013

Link zum Volltext

Verfügbarkeit prüfen

Normative spatiotemporal gait parameters in older adults

Gait & posture, 2011-05, Vol.34 (1), p.111-118

2011

Link zum Volltext

Verfügbarkeit prüfen

Reply to “Thinking beyond Aducanumab Controversy”

Annals of neurology, 2021-12, Vol.90 (6), p.1004-1004

Petersen, Ronald

2021

Link zum Volltext

Verfügbarkeit prüfen

Mild cognitive impairment: an overview

CNS spectrums, 2008-01, Vol.13 (1), p.45

2008

Link zum Volltext

Verfügbarkeit prüfen

Non-stationarity in the "resting brain's" modular architecture

PloS one, 2012-06, Vol.7 (6), p.e39731-e39731

2012

Link zum Volltext

Verfügbarkeit prüfen

Mild Cognitive Impairment in Geriatrics

Clinics in geriatric medicine, 2018-11, Vol.34 (4), p.563

2018

Link zum Volltext

Verfügbarkeit prüfen

Cascading network failure across the Alzheimer's disease spectrum

Brain (London, England : 1878), 2016-02, Vol.139 (Pt 2), p.547-562

2016

Link zum Volltext

Verfügbarkeit prüfen

Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease

The FASEB journal, 2015-02, Vol.29 (2), p.589-596

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study

Alzheimer's & dementia, 2015-06, Vol.11 (6), p.600-607.e1

2015

Link zum Volltext

Verfügbarkeit prüfen

Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study

Lancet neurology, 2011-09, Vol.10 (9), p.785-796

2011

Link zum Volltext

Verfügbarkeit prüfen

Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study

Lancet neurology, 2012-10, Vol.11 (10), p.868-877

2012

Link zum Volltext

Verfügbarkeit prüfen

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

Annals of neurology, 2012-10, Vol.72 (4), p.578-586

2012

Link zum Volltext

Verfügbarkeit prüfen

Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia

JAMA neurology, 2016-01, Vol.73 (1), p.93

2016

Link zum Volltext

Verfügbarkeit prüfen

Defining imaging biomarker cut points for brain aging and Alzheimer's disease

Alzheimer's & dementia, 2017-03, Vol.13 (3), p.205-216

2017

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

Movement disorders, 2012-03, Vol.27 (3), p.349-356

2012

Link zum Volltext

Verfügbarkeit prüfen

Mild Cognitive Impairment

The New England journal of medicine, 2011-06, Vol.364 (23), p.2227-2234

Petersen, Ronald C

2011

Link zum Volltext

Verfügbarkeit prüfen

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

Alzheimer's & dementia, 2011-05, Vol.7 (3), p.270-279

2011

Link zum Volltext

Verfügbarkeit prüfen

Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study

Lancet neurology, 2017-06, Vol.16 (6), p.435-444

2017

Link zum Volltext

Verfügbarkeit prüfen

Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression

Brain (London, England : 1878), 2019-04, Vol.142 (4), p.1077-1092

2019

Link zum Volltext

Verfügbarkeit prüfen

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Lancet neurology, 2010, Vol.9 (1), p.119-128

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.043

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.938)
Mit Volltextzugriff
(1.748)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives

Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics

Physical Exercise as a Preventive or Disease-Modifying Treatment of Dementia and Brain Aging

Mild Cognitive Impairment and Mild Dementia: A Clinical Perspective

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Normative spatiotemporal gait parameters in older adults

Reply to “Thinking beyond Aducanumab Controversy”

Mild cognitive impairment: an overview

Non-stationarity in the "resting brain's" modular architecture

Mild Cognitive Impairment in Geriatrics

Cascading network failure across the Alzheimer's disease spectrum

Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study

Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study

Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia

Defining imaging biomarker cut points for brain aging and Alzheimer's disease

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

Mild Cognitive Impairment

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study

Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Suchergebnisse filtern